Global Oligonucleotide Synthesis Market to Value Over USD 4 Billion by 2026 End

  • 26 Aug 2019

The oligonucleotide synthesis market is anticipated to value over USD 4 billion by 2026 with a CAGR of over 12% during the forecast period 2019 to 2026.

Oligonucleotide synthesis is the process of compounding relatively short fragments of nucleic acid with a defined sequence. It is a vital part of genetic research and has a wide range of applications like diagnosis, tissue engineering, library preparation, DNA sequencing, PCR assays and so on. Due to such scope in the research and development, the oligonucleotide market is growing rapidly.

The inclination towards finding more efficient alternatives to traditional diagnostics and treatments is one of the factors driving the scale-up of the oligonucleotide synthesis market. For the past few years, several genetic diagnostic and clinical measures have boosted the market of oligonucleotide synthesis.

The oligonucleotide synthesizing equipment is expected to hold a large market share as they are the primary preference of end users. The key market players provide a range of synthesizers that add value to the market. Oligonucleotide synthesis is impossible without suitable reagents like linkers, activators, dyes, DNA probes and so on. This is a driving factor for the rise in demand for reagents in the market and is anticipated to hold a large oligonucleotide synthesis market share.

Based on the applications, PCR primers and fluorescence in situ hybridization are anticipated to dominate the oligonucleotide synthesis market due to its wide use across the globe.

Currently, the pharmaceutical and biotechnological companies have their focus on the genetic sector for effective therapeutics and diagnostics. The investments by these companies in genetic research are factors responsible for the oligonucleotide synthesis market growth.

North America region has its main focus on genetic research and development, it also possesses advanced technology as well as regulatory support for the study of genetic advancements. This factor dominates North America in the oligonucleotide synthesis market. Moreover, the Asia Pacific region has a good scope in the market due to inclination towards adopting genetic research.

The key market players are Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare Dharmacon Inc., Agilent Technologies and so on. Thermo Fisher Scientific has a range of advanced genetic equipment with several applications like DNA sequencing, PCR, protein biology, etc. which are anticipated to be drivers for the market growth.

FutureWise Key Takeaways:

●    Investment in genetic research

●    Focus on advanced genetic synthesizers

●    Collaborations with genetic research organizations

Global Oligonucleotide Synthesis Market Segmentation:

By Product:

●    Oligonucleotides

●    Equipment/ synthesizers

●    Reagents

●    Services

By Application:

●    PCR primers

●    PCR assays-panels

●    Sequencing

●    DNA microarrays

●    Fluorescence in situ hybridization

●    Antisense oligonucleotides

●    Other applications

By End User:

●    Pharmaceutical-biotechnology companies

●    Diagnostic laboratories

●    Academic research institutes

By Region

●    North America

●    Europe

●    Asia Pacific

●    Latin America

●    Middle East & Africa

Competitive Landscape:

●    Tier 1 players- established companies in the market with a major market share

●    Tier 2 players

●    Emerging players which are growing rapidly

●    New Entrants   

Objectives of the Study:

●    To provide with an exhaustive analysis on the oligonucleotide synthesis market by product, by application, by end user and by region

●    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

●    To evaluate and forecast micro-markets and the overall market

●    To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa

●    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

●    Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Get unlimited analyst support and customise this study further to your requirements, contact